Literature DB >> 32416310

Arterial and venous thrombosis: What's the link? A narrative review.

Aurélien Delluc1, Karine Lacut2, Marc A Rodger3.   

Abstract

Arterial thrombosis and venous thromboembolism (VTE) are traditionally considered two different entities. However, patients with unprovoked VTE are at higher risk of developing subclinical and overt atherosclerosis compared to healthy controls challenging these distinctions. Obesity may explain the association between arterial and venous disease: overweight/obese patients are prone to stasis in lower limbs veins, chronic inflammation, dyslipidemia, hypertension, and diabetes mellitus; all of which result in a hypercoagulability, VTE, and atherosclerosis. Novel therapeutic approaches combining and re-purposing traditional arterial therapies (antiplatelets and statins) and venous thrombosis therapies (anticoagulants) are emerging for the management of patients with vascular disease.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticoagulants; Atherosclerosis; Statins; Venous thromboembolism

Mesh:

Substances:

Year:  2020        PMID: 32416310     DOI: 10.1016/j.thromres.2020.04.035

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis.

Authors:  Setor K Kunutsor; Jari A Laukkanen
Journal:  Thromb Res       Date:  2020-08-11       Impact factor: 3.944

2.  Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society.

Authors:  Frederikus A Klok; Walter Ageno; Cihan Ay; Magnus Bäck; Stefano Barco; Laurent Bertoletti; Cecilia Becattini; Jørn Carlsen; Marion Delcroix; Nick van Es; Menno V Huisman; Luis Jara-Palomares; Stavros Konstantinides; Irene Lang; Guy Meyer; Fionnuala Ní Áinle; Stephan Rosenkranz; Piotr Pruszczyk
Journal:  Eur Heart J       Date:  2022-01-25       Impact factor: 29.983

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.